Skip to main content

Animations

MJFF Publications

7681 - 7690 of 8808 Results
Title
Year
  • Year
  • 2018
  • 2023
  • 2018
  • 2023
  • 2015
  • 2024
  • 2017
  • 2023
  • 2014
  • 2025
  • Summary Details
    RESTRICTED
    Title: A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p5.068
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Network connectivity and local transcriptomic vulnerability underpin cortical atrophy progression in Parkinson’s disease
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2023.103523
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease
    Journal Name: Journal of Tissue Engineering and Regenerative Medicine
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/term.2698
    Citation Count: 58
  • Summary Details
    OPEN
    Title: Imaging-based DBS programming help: Does it help?
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105362
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26251
    Citation Count: 106
  • Summary Details
    OPEN
    Title: Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.92775
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Discovery and functional prioritization of Parkinson’s disease candidate genes from large-scale whole exome sequencing
    Journal Name: Genome Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13059-017-1147-9
    Citation Count: 114
  • Summary Details
    OPEN
    Title: The 5‐HT2A/2C inverse agonist nelotanserin alleviates L‐DOPA‐induced dyskinesia in the MPTP‐lesioned marmoset
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.16104
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Correlation between orphan nuclear receptor Nurr1 expression and amyloid deposition in 5XFADmice, an animal model of Alzheimer's disease
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.12935
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Bradykinesia and postural instability in a model of prodromal synucleinopathy with α-synuclein aggregation initiated in the gigantocellular nuclei
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1186/s40478-025-01948-7
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.